Clinical Trials
73 trialsA Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer
Hebei Medical University Fourth Hospital
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
GE Healthcare
Neoadjuvant Serplulimab & Bevacizumab With FOLFOX vs. FOLFOX Alone in RAS/BRAF WT, pMMR/MSS CRC Patients
Sun Yat-sen University
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
Shanghai 10th People's Hospital
CAIRO6
Catharina Ziekenhuis Eindhoven
DETERMINE
Cancer Research UK
Intensified Chemotherapy in CRC After Resection of Liver Metastases
Institut du Cancer de Montpellier - Val d'Aurelle
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
Alliance for Clinical Trials in Oncology
INJECTABL-3
Immunophotonics, Inc.
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer
Jiangsu HengRui Medicine Co., Ltd.
Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor in Metastatic pMMR/MSS Colorectal Cancer (MODIFI-CRC)
Sixth Affiliated Hospital, Sun Yat-sen University
ASAC
Oslo University Hospital
Fruquintinib With or Without HAI-FOLFOX for Refractory Colorectal Cancer
Sun Yat-sen University
A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
Seattle Project Corporation
A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)
Sun Yat-sen University
REPROGRAM-02
Centre Hospitalier Universitaire de Besancon
PACHA-01
Gustave Roussy, Cancer Campus, Grand Paris
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
Shanghai Henlius Biotech
COLDFIRE-III
Amsterdam UMC, location VUmc
TROPHIT1
University Hospital Heidelberg
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
CheckMate 9X8
Bristol-Myers Squibb
Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
King Hussein Cancer Center
FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues
Cancer Hospital of Guangxi Medical University
Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
Second Affiliated Hospital, School of Medicine, Zhejiang University
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer
Ruijin Hospital
Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC
Ruijin Hospital
PARECEC
Peking University Cancer Hospital & Institute
SUNRISE-CRC
Amsterdam UMC, location VUmc
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
Odense University Hospital
PUMP-IT
The Netherlands Cancer Institute
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
Federation Francophone de Cancerologie Digestive
Aspirin/Folate Prevention of Large Bowel Polyps
Dartmouth-Hitchcock Medical Center
AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer
Mirror Biologics, Inc.
Effect of Cancer Nurse Navigators on Patient Outcomes
University of Wisconsin, Madison
ALTER0703
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
FOxTROT
University of Birmingham
CRC009
Shanghai Zhangjiang Biotechnology Limited Company
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
Dong-A University Hospital
Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III
State Key Laboratory of Cancer Biology
BOS3
European Organisation for Research and Treatment of Cancer - EORTC
HORIZON III
AstraZeneca
Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Vitamin D/Calcium Polyp Prevention Study
Dartmouth-Hitchcock Medical Center
Cetuximab Monotherapy Maintenance Treatment in mCRC
Ruijin Hospital